These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 27571742

  • 1. Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.
    Fan MD, Kramzer LF, Hillier SL, Chang JC, Meyn LA, Rohan LC.
    Arch Sex Behav; 2017 May; 46(4):1111-1119. PubMed ID: 27571742
    [Abstract] [Full Text] [Related]

  • 2. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
    J Int AIDS Soc; 2015 May; 18(1):20536. PubMed ID: 26700845
    [Abstract] [Full Text] [Related]

  • 3. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]

  • 4. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
    Nel AM, Mitchnick LB, Risha P, Muungo LT, Norick PM.
    J Womens Health (Larchmt); 2011 Aug 01; 20(8):1207-14. PubMed ID: 21774672
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
    Weinrib R, Browne EN, Shapley-Quinn MK, van der Straten A, Beksinska M, Mgodi N, Musara P, Mphili N, Schwartz JL, Ju S, Hanif H, Montgomery ET, Quatro Study Team.
    AIDS Behav; 2020 Feb 01; 24(2):637-647. PubMed ID: 31254190
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.
    Woodsong C, Holt JD.
    Adv Drug Deliv Rev; 2015 Sep 15; 92():146-54. PubMed ID: 25703190
    [Abstract] [Full Text] [Related]

  • 9. Microbicide preference among young women in California.
    Holt BY, Morwitz VG, Ngo L, Harrison PF, Whaley KJ, Pettifor A, Nguyen AH.
    J Womens Health (Larchmt); 2006 Apr 15; 15(3):281-94. PubMed ID: 16620187
    [Abstract] [Full Text] [Related]

  • 10. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, MTN-003D Study Team.
    J Int AIDS Soc; 2016 Apr 15; 19(1):20875. PubMed ID: 27247202
    [Abstract] [Full Text] [Related]

  • 11. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
    Whitehead SJ, McLean C, Chaikummao S, Braunstein S, Utaivoravit W, van de Wijgert JH, Mock PA, Siraprapasiri T, Friedland BA, Kilmarx PH, Markowitz LE.
    PLoS One; 2011 Apr 15; 6(9):e14831. PubMed ID: 21915249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
    Abdulai MA, Baiden F, Adjei G, Afari-Asiedu S, Adjei K, Tawiah C, Newton S.
    BMC Womens Health; 2012 Nov 01; 12():40. PubMed ID: 23114222
    [Abstract] [Full Text] [Related]

  • 14. Design aspects of vaginal applicators that influence acceptance among target users.
    Bakke AJ, Zaveri T, Higgins MJ, Ziegler GR, Hayes JE.
    Sci Rep; 2021 May 07; 11(1):9802. PubMed ID: 33963262
    [Abstract] [Full Text] [Related]

  • 15. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.
    Braunstein S, van de Wijgert J.
    J Womens Health (Larchmt); 2005 Jun 07; 14(5):424-33. PubMed ID: 15989415
    [Abstract] [Full Text] [Related]

  • 16. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.
    AIDS Behav; 2015 May 07; 19(5):784-93. PubMed ID: 25416076
    [Abstract] [Full Text] [Related]

  • 17. Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.
    Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S, HIV Prevention Trial Network 047 Protocol Team.
    AIDS Care; 2007 Jul 07; 19(6):817-21. PubMed ID: 17573603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.